NCT05513716Recruiting
Molecular Characterisation of Colorectal Cancer Peritoneal Metastases
Molecular Characterisation of Colorectal Cancer Peritoneal Metastases: Genomic and Transcriptomic Analysis With Correlation of Clinical Outcomes
Source: ClinicalTrials.gov · Last updated 1 Jan 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This project aims to characterise the tumour cell and tumour microenvironment of colorectal cancer peritoneal metastases, understand molecular changes leading to colorectal peritoneal metastasis, identify potential biomarkers and novel treatment strategies.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 200 (estimated)
- First submitted
- 22 Aug 2022
- Start date
- 4 Feb 2024
- Primary completion date
- 3 Jul 2025
- Lead sponsor
- The Christie NHS Foundation Trust
- Diseases
- Colorectal cancer
- NCT number
- NCT05513716
What you commit to
- Study type: Observational
- Planned participants: 200
- From 4 Feb 2024 to the primary completion date, 3 Jul 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- None
Criteria the registry did not label
- Participants are eligible to be included in the study only if all of the following criteria apply:
- Patients ≥ 18 years old who have been diagnosed with colorectal cancer and have colorectal peritoneal metastases,
- have had cytoreductive surgery at the Christie
- have availability of archival tumour tissue (paired CRC and CRPM)
Age in the registry: 18 years to - · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Christie Hospital NHS Foundation Trust Coordinator of this site? Confirm its status | Manchester | United Kingdom | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.